New Opportunity: EnteroMedics Inc. (NasdaqCM: ETRM)
We would like to bring to your attention a brand new NASDAQ trade opportunity that appears to suggest significant upside opportunity in the short-term.
The last few alerts unfortunately have not been superb for us, but if you recall, at one point we were sitting with alerts that provided us with over 400% in upside. As is the case with trading, unfortunately with the gains come the losses.
Today’s alert opened at 1.96 and rallied to a high of 2.05 for upside of 4%, however we are not overly excited about that. Our goal is to focus on trade opportunities that provide you with massive upside volatility.
As such, we have come across a brand new alert that we believe may be positioned for superb upside.
Company: EnteroMedics Inc.
Latest News: http://finance.yahoo.com/q/h?s=ETRM+Headlines
Company Website: http://www.enteromedics.com
New Trade Alert: EnteroMedics Inc. (NASDAQ: ETRM)
This NASDAQ listed company trades at only 14 cents, and has recently traded as high as 1.00. Make note, our goal is not to anticipate such a move. This only goes to demonstrate the type of volatility this company has experienced in the recent past.
ETRM has a 20 day moving average at 0.17, which acts as a near term resistance above current valuation by 21%.
If the 20 day moving average is surpassed the next possible resistance level could be the 50 day moving average at 0.22 for upside of 57% from current valuation.
What You Need To Know:
- ETRM has a small trading float of just 26.60M, which suggests the stock could launch higher on any additional influx of interest.
- ETRM is making real money, with trailing revs already coming in at $561.00k.
- ETRM is starting to see major topline growth, with quarterly y/y revs increasing at 249%.
- ETRM is showing a clear surge in interest, with volume over the last couple weeks tracking 160% above its recent average levels.
- ETRM is coming off an RSI trough under 40, pointing to a massively oversold stock now heading back the other way.
ETRM experienced what may potentially prove to be a reversal, after it jumped during today’s trading after yesterday’s reversal candle.
ETRM has witnessed incredible volume over the past few weeks, suggestive of increased opportunity to experience momentum.
Please note that ETRM could be extremely volatile and that we are monitoring this for short term gain potential only.
ETRM reported breaking news today that appears to have been received well by markets: EnteroMedics Announces Appointment of Scott Youngstrom as Chief Financial Officer and Chief Compliance Officer
ST. PAUL, Minn., Sept. 7, 2016 /PRNewswire/ — EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the appointment of Scott Youngstrom as Chief Financial Officer and Chief Compliance Officer, effective October 3, 2016. Scott will succeed Greg Lea, EnteroMedics’ current Chief Financial Officer and Chief Compliance Officer, who will be retiring from the Company effective October 3, 2016, as previously announced.
ETRM (EnteroMedics Inc.) EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses.
ETRM develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity.